Quantbot Technologies LP Has $8.10 Million Stake in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Quantbot Technologies LP lifted its holdings in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 17.5% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 126,254 shares of the company's stock after acquiring an additional 18,836 shares during the period. Quantbot Technologies LP's holdings in Ryan Specialty were worth $8,100,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Sanctuary Advisors LLC lifted its holdings in shares of Ryan Specialty by 1.2% during the 4th quarter. Sanctuary Advisors LLC now owns 15,690 shares of the company's stock worth $1,045,000 after acquiring an additional 188 shares during the period. State of Alaska Department of Revenue lifted its holdings in Ryan Specialty by 1.6% during the 4th quarter. State of Alaska Department of Revenue now owns 12,130 shares of the company's stock valued at $778,000 after purchasing an additional 190 shares during the last quarter. CIBC Asset Management Inc lifted its holdings in Ryan Specialty by 5.6% during the 4th quarter. CIBC Asset Management Inc now owns 3,674 shares of the company's stock valued at $236,000 after purchasing an additional 196 shares during the last quarter. Loomis Sayles & Co. L P lifted its holdings in Ryan Specialty by 26.3% during the 3rd quarter. Loomis Sayles & Co. L P now owns 1,373 shares of the company's stock valued at $91,000 after purchasing an additional 286 shares during the last quarter. Finally, Exchange Traded Concepts LLC lifted its holdings in Ryan Specialty by 2.6% during the 4th quarter. Exchange Traded Concepts LLC now owns 11,760 shares of the company's stock valued at $755,000 after purchasing an additional 295 shares during the last quarter. 84.82% of the stock is owned by institutional investors.

Remove Ads

Ryan Specialty Price Performance

RYAN traded down $0.27 during midday trading on Tuesday, hitting $71.08. The company had a trading volume of 842,239 shares, compared to its average volume of 909,299. The company has a debt-to-equity ratio of 2.40, a quick ratio of 1.01 and a current ratio of 1.01. The company has a market capitalization of $18.62 billion, a PE ratio of 103.01, a P/E/G ratio of 1.19 and a beta of 0.71. The firm's 50-day simple moving average is $67.30 and its 200-day simple moving average is $67.81. Ryan Specialty Holdings, Inc. has a twelve month low of $48.48 and a twelve month high of $75.97.

Ryan Specialty (NYSE:RYAN - Get Free Report) last announced its quarterly earnings data on Thursday, February 20th. The company reported $0.45 earnings per share for the quarter, missing the consensus estimate of $0.47 by ($0.02). Ryan Specialty had a net margin of 9.14% and a return on equity of 48.01%. The business had revenue of $663.53 million during the quarter, compared to analyst estimates of $658.80 million. Equities research analysts predict that Ryan Specialty Holdings, Inc. will post 2.29 EPS for the current fiscal year.

Ryan Specialty Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 18th. Stockholders of record on Tuesday, March 4th will be given a $0.12 dividend. This is a positive change from Ryan Specialty's previous quarterly dividend of $0.11. This represents a $0.48 annualized dividend and a dividend yield of 0.68%. The ex-dividend date of this dividend is Tuesday, March 4th. Ryan Specialty's dividend payout ratio (DPR) is currently 69.57%.

Wall Street Analyst Weigh In

RYAN has been the subject of several analyst reports. Royal Bank of Canada cut their price target on shares of Ryan Specialty from $73.00 to $72.00 and set a "sector perform" rating for the company in a report on Friday, February 21st. Wells Fargo & Company lifted their price target on shares of Ryan Specialty from $64.00 to $69.00 and gave the company an "equal weight" rating in a report on Friday, February 21st. Barclays lifted their price target on shares of Ryan Specialty from $76.00 to $88.00 and gave the company an "overweight" rating in a report on Thursday, November 21st. Keefe, Bruyette & Woods cut their price target on shares of Ryan Specialty from $77.00 to $76.00 and set an "outperform" rating for the company in a report on Friday, February 21st. Finally, Morgan Stanley assumed coverage on shares of Ryan Specialty in a report on Thursday, December 5th. They set an "overweight" rating and a $90.00 price target for the company. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and six have given a buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average price target of $75.27.

Insider Transactions at Ryan Specialty

In other news, EVP Brendan Martin Mulshine sold 30,000 shares of the firm's stock in a transaction on Friday, March 14th. The stock was sold at an average price of $69.30, for a total value of $2,079,000.00. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, Director Nicholas Dominic Cortezi sold 29,466 shares of the firm's stock in a transaction on Monday, January 13th. The stock was sold at an average price of $65.06, for a total value of $1,917,057.96. Following the completion of the transaction, the director now owns 45,409 shares in the company, valued at $2,954,309.54. This represents a 39.35 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 276,451 shares of company stock worth $18,293,293 in the last three months. Insiders own 11.10% of the company's stock.

Ryan Specialty Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.